Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,816.89
(
-0.11%
)
US TECH 100
24,499.60
(
0.38%
)
Dow Jones
47,916.57
(
-0.56%
)
Brent Oil
98.45
(
-1.40%
)
Bitcoin
71,271.48
(
0.70%
)
News Focus
News Focus
Post# of 821150
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jammyjames

Send PM Follow Ignore
Followers 16
Posts 672
Boards Moderated 0
Alias Born 01/06/2017

jammyjames

Re: flipper44 post# 212749

Tuesday, 02/05/2019 5:30:49 AM

Tuesday, February 05, 2019 5:30:49 AM

Post# of 821150
also i'd add that the whole point of a phase I is to assess satefy and tolerability. I imagine that for immuno-oncology phase Is they select patients that have optimal prognosis....it's pretty hard to ascertain safety and tolerability for a given treatment that lasts years if the patients don't live that long.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent NWBO News
More NWBO News